Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1087041

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the PACE trial of therapies on reducing the effects of (a) myalgic encephalomyelitis and (b) chronic fatigue syndrome.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	231512
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>The PACE trial, undertaken by Queen Mary University of London, was the largest ever trial of therapies for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). The trial aimed to test and compare the effectiveness of four of the main treatments available for people CFS/ME. These were adaptive pacing therapy, cognitive behaviour therapy (CBT), graded exercise therapy, and standardised specialist medical care (SMC).</p><p> </p><p>The five-year trial involved over 600 participants, aged 18 and over, in Scotland and England. The first set of results from the trial were published in 2011 in the Lancet, and a number of other evaluations based on the trial have been published since. The trial results found both CBT and GET were moderately effective when provided alongside SMC and were better than adaptive pacing therapy or SMC alone in improving both symptoms and disability.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children’, sets outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition. The guideline recommends CBT and GET as appropriate treatments for mild to moderate CFS/ME, in line with the best available evidence.</p><p> </p><p>The NICE guideline acknowledges that there is no one form of treatment to suit every patient and that treatment and care should take into account the personal needs and preferences of the patient. Decisions concerning the appropriateness of treatments should be made on a case by case basis.</p><p> </p><p>On 20 September 2017, NICE announced its decision to undertake a full update of the guideline, following a review of the latest available evidence on the diagnosis and management of CFS/ME and a public consultation. New guidance is expected in October 2020. More information on this decision can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me" target="_blank">www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:33:27 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1087043

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Disadvantaged
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to allocate funding for the ten-year review of progress on reducing health inequalities since the publication of the report entitled Fair Society, Healthy Lives, published by Michael Marmot.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	231513
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>We have no current plans to allocate funding to the Institute of Health Equity and Health Foundation review of Fair Society, Healthy Lives. We look forward to seeing the review’s conclusions in February 2020. Reducing health inequalities remains a priority for the Department and is central to the NHS Long Term Plan and the Secretary of State’s prevention priority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/03/2019 16:24:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4433 label Biography information for Thangam Debbonaire

1087066

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Birmingham
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Care Quality Commission report on medical services for homeless citizens in Birmingham, published in October 2018, when he plans to re-tender the service; and if he will lay a copy of the specification for their service in the Library.
tabling member constituency	Birmingham, Hodge Hill
tabling member printed	Liam Byrne
uin	231371
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>The provision of this service is the responsibility of the local clinical commissioning group, (Birmingham and Solihull Clinical Commissioning Group). The current service will remain in place until the clinical commissioning group considers and agrees its commissioning plan for the service going forward; it is anticipated that the plan will be agreed in the very near future.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:38:35 answering member 4067 label Biography information for Steve Brine
tabling member	1171 label Biography information for Liam Byrne

1087090

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Infectious Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the proposed NHS Tariff and its alignment with the commitments set out in the NHS 10 Point Efficiency Plan on reducing infection rates in hospitals in the field of ophthalmology.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	231465
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>The national tariff is not designed to incentivise or reward providers around infection rates. Other mechanisms are employed to support the National Health Service to reduce infection rates.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/03/2019 16:20:16 answering member 1585 label Biography information for Stephen Hammond
tabling member	4131 label Biography information for Jim Shannon

1087091

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Infectious Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress the Government has made on reducing infection rates in hospitals; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	231466
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>Public Health England (PHE) collects data on the number of healthcare associated infections as part of the English Surveillance Programme for Antimicrobial Utilisation and Resistance, available at the following link:</p><p><a href="https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report" target="_blank">https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report</a></p><p>The latest data show cases of hospital-onset Clostridium difficile infection decreased by 18% from 1,149 in October-December 2017 to 938 in the same period in 2018. Hospital-onset Methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli bloodstream infections remained stable over the last five years although hospital-onset Methicillin-sensitive Staphylococcus aureus (MSSA) cases have increased slightly. This data can be found in the Epidemiological Commentary on mandatory surveillance and is available to view at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/739910/Quarterley_Epidemiology_Commentary_September_18.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/739910/Quarterley_Epidemiology_Commentary_September_18.pdf</a></p><p>PHE supports NHS Improvement by making local data on rates of healthcare-associated infections available to hospitals and clinical commissioning groups via its Fingertips web portal available at the following link:</p><p><a href="https://fingertips.phe.org.uk/profile/amr-local-indicators" target="_blank">https://fingertips.phe.org.uk/profile/amr-local-indicators</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:36:29 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1087092

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ophthalmic Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many procedures for glaucoma were undertaken alongside cataract treatment in the last year; and whether his Department has made an assessment of the effectiveness of that combined treatment.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	231467
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>There were 2,742 National Health Service finished consultant episodes in 2017/18 in England, where a procedure for treating cataract and glaucoma occurred at the same time. This is not a count of patients, given patients may have more than one episode of care during the same period.</p><p> </p><p>No assessment has been made by the Department of the effectiveness of combining cataract and glaucoma treatment. Decisions on whether to recommend concomitant treatment are for individual clinicians’ taking into account individual clinical circumstances, the patient’s wishes and the best available evidence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:42:16 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1087154

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2019 to Question 226647 on Medical Treatments, from which budget would an increase to the list price of a branded medicine be met in the event that his Department agreed such an increase.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	231424
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>In such an event, an increase in the list price of a branded medicine cost would be borne by clinical commissioning groups who receive prescribing funding as part of the annual allocations process from NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:41:34 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

1087173

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of the February 2019 National Aids Trust report, Drug-related Deaths in England, what steps his Department is taking to ensure adequate provision of naloxone for people at risk of overdose.
tabling member constituency	Portsmouth South
tabling member printed	Stephen Morgan
uin	231551
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>Local authorities are responsible for assessing local needs and commissioning drug prevention, treatment and harm reduction services to meet these needs. This includes making sure they have sufficient coverage of take-home naloxone to prevent drug-related deaths.</p><p> </p><p>The Government is encouraging and supporting local areas to expand the provision of naloxone, with guidance, advice and tools.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 231552 question first answered 20/03/2019 16:39:41 answering member 4067 label Biography information for Steve Brine
tabling member	4653 label Biography information for Stephen Morgan

1087178

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the National Aids Trust report of 5 February 2019, Drug-related deaths in England, if the Government will make an assessment of the potential merits of introducing a national naloxone programme.
tabling member constituency	Portsmouth South
tabling member printed	Stephen Morgan
uin	231552
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>Local authorities are responsible for assessing local needs and commissioning drug prevention, treatment and harm reduction services to meet these needs. This includes making sure they have sufficient coverage of take-home naloxone to prevent drug-related deaths.</p><p> </p><p>The Government is encouraging and supporting local areas to expand the provision of naloxone, with guidance, advice and tools.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 231551 question first answered 20/03/2019 16:39:41 answering member 4067 label Biography information for Steve Brine
tabling member	4653 label Biography information for Stephen Morgan

1087180

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of drug consumption rooms on (a) providing people with harm reduction information and advice and (b) supporting people to engage with a structured drug treatment.
tabling member constituency	Portsmouth South
tabling member printed	Stephen Morgan
uin	231554
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>No assessment of the effectiveness of drug consumption rooms (DCR) has been made. There is no legal framework for the provision of DCRs in the United Kingdom and the Government has no plans to introduce them. Legislation on this issue is a matter for the Home Office.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:40:44 answering member 4067 label Biography information for Steve Brine
tabling member	4653 label Biography information for Stephen Morgan